Nothing Special   »   [go: up one dir, main page]

AU6309890A - Stabilized leukocyte-interferons - Google Patents

Stabilized leukocyte-interferons

Info

Publication number
AU6309890A
AU6309890A AU63098/90A AU6309890A AU6309890A AU 6309890 A AU6309890 A AU 6309890A AU 63098/90 A AU63098/90 A AU 63098/90A AU 6309890 A AU6309890 A AU 6309890A AU 6309890 A AU6309890 A AU 6309890A
Authority
AU
Australia
Prior art keywords
interferons
leukocyte
stabilized
stabilized leukocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU63098/90A
Other versions
AU636653B2 (en
Inventor
Alberto Ferro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU6309890A publication Critical patent/AU6309890A/en
Application granted granted Critical
Publication of AU636653B2 publication Critical patent/AU636653B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63098/90A 1989-09-28 1990-09-21 Stabilized leukocyte-interferons Expired - Fee Related AU636653B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3514/89 1989-09-28
CH351489 1989-09-28

Publications (2)

Publication Number Publication Date
AU6309890A true AU6309890A (en) 1991-04-11
AU636653B2 AU636653B2 (en) 1993-05-06

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63098/90A Expired - Fee Related AU636653B2 (en) 1989-09-28 1990-09-21 Stabilized leukocyte-interferons

Country Status (26)

Country Link
EP (1) EP0420049B1 (en)
JP (1) JPH03130232A (en)
KR (1) KR910005886A (en)
CN (1) CN1050503A (en)
AR (1) AR244551A1 (en)
AT (1) ATE92334T1 (en)
AU (1) AU636653B2 (en)
CA (1) CA2024046A1 (en)
CZ (1) CZ277712B6 (en)
DD (1) DD298054A5 (en)
DE (1) DE59002183D1 (en)
FI (1) FI904756A0 (en)
HU (1) HU205555B (en)
IE (1) IE903479A1 (en)
IL (1) IL95769A0 (en)
IS (1) IS3631A7 (en)
MC (1) MC2149A1 (en)
MX (1) MX22522A (en)
MY (1) MY106615A (en)
NO (1) NO904218L (en)
NZ (1) NZ235153A (en)
PH (1) PH27531A (en)
PT (1) PT95454A (en)
RU (1) RU2008017C1 (en)
YU (1) YU184090A (en)
ZA (1) ZA907579B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
WO1998051328A1 (en) * 1997-05-09 1998-11-19 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
AU2401197A (en) * 1996-05-09 1997-11-26 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
CZ302005B6 (en) * 1998-03-26 2010-09-01 Schering Corporation Aqueous agent of PEG-interferon alpha conjugate, lyophilizate thereof and product containing it
CN1175901C (en) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 Stable water solution of interferon
EP1796647B1 (en) 2004-08-12 2010-08-11 Schering Corporation Stable pegylated interferon formulation
DE102004048379A1 (en) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Spring element made of sputtered shape memory alloy
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (en) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd Purifying method of interferon
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
ATE31023T1 (en) * 1983-04-28 1987-12-15 Armour Pharma PHARMACEUTICAL PREPARATION CONTAINING PURIFIED FIBRINONECTIN.
DE3484374D1 (en) * 1983-08-04 1991-05-08 Green Cross Corp GAMMA INTERFERON COMPOSITION.
FI861193A (en) * 1985-03-25 1986-09-26 Schering Corp STABILT GAMMAINTERFERONPREPARAT.
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
MX22522A (en) 1993-10-01
EP0420049B1 (en) 1993-08-04
CA2024046A1 (en) 1991-03-29
HUT56284A (en) 1991-08-28
RU2008017C1 (en) 1994-02-28
EP0420049A1 (en) 1991-04-03
NO904218D0 (en) 1990-09-27
IS3631A7 (en) 1991-03-29
NO904218L (en) 1991-04-02
HU906021D0 (en) 1991-03-28
FI904756A0 (en) 1990-09-27
ZA907579B (en) 1991-06-26
IL95769A0 (en) 1991-06-30
MC2149A1 (en) 1992-03-10
CS432890A3 (en) 1992-12-16
CN1050503A (en) 1991-04-10
MY106615A (en) 1995-06-30
YU184090A (en) 1992-09-07
CZ277712B6 (en) 1993-03-17
PT95454A (en) 1991-05-22
IE903479A1 (en) 1991-04-10
KR910005886A (en) 1991-04-27
HU205555B (en) 1992-05-28
AU636653B2 (en) 1993-05-06
ATE92334T1 (en) 1993-08-15
AR244551A1 (en) 1993-11-30
PH27531A (en) 1993-08-18
NZ235153A (en) 1993-03-26
DD298054A5 (en) 1992-02-06
JPH03130232A (en) 1991-06-04
DE59002183D1 (en) 1993-09-09

Similar Documents

Publication Publication Date Title
AU5748990A (en) Venoscope
AU5874690A (en) Octreotide-pamoate
AU5348790A (en) Micro-multi-electrode arrangement
AU623795B2 (en) New substituted 1h-indazole-3-carboxamides
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU5064390A (en) Downcomer-tray assembly
AU623262B2 (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU631622B2 (en) Snow-vehicle
AU623780B2 (en) Chromanderivate
AU5808490A (en) Vip-analogs 11
AU4169089A (en) (Diarylmethoxy)-1-pyrrolidines and-piperidines
AU5583190A (en) Compounds
AU632104B2 (en) Substituted pyrimidin-6-ones(-6-thiones)
AU6309890A (en) Stabilized leukocyte-interferons
AU5336690A (en) Leg-guard
AU6627590A (en) Doll-container
AU5782590A (en) Thioxotetrazolines
AU6839190A (en) Triazolylsulfonamides
AU5400390A (en) Substituted 1-phenylnaphthalenes
AU5195790A (en) Ligthead assembly
AU6268590A (en) Aminophosphinates
AU5915590A (en) Certain glyoxyl-cyclohexendiones
AU4944090A (en) Cryoelectrosynthesis
AU6217090A (en) Substituted amino-pyridines